Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Warner Chilcott

(

WCRX

) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.2%. By the end of trading, Warner Chilcott rose $0.25 (1.2%) to $21.29 on average volume. Throughout the day, 5,422,766 shares of Warner Chilcott exchanged hands as compared to its average daily volume of 6,991,800 shares. The stock ranged in a price between $21.05-$21.51 after having opened the day at $21.16 as compared to the previous trading day's close of $21.04. Other companies within the Health Care sector that increased today were:

Reliv' International

(

RELV

), up 54.8%,

Synta Pharmaceuticals

(

SNTA

), up 41.3%,

Idera Pharmaceuticals

(

IDRA

), up 38.0% and

Spherix

(

SPEX

), up 26.3%.

Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the women's healthcare, gastroenterology, urology, and dermatology markets. Warner Chilcott has a market cap of $5.1 billion and is part of the drugs industry. Shares are down 2.1% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Warner Chilcott a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Warner Chilcott as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and weak operating cash flow.

On the negative front,

Mast Therapeutics

(

MSTX

), down 37.9%,

Pingtan Marine Enterprise

(

PME

), down 11.1%,

Hyperion Therapeutics

(

HPTX

), down 8.2% and

Chelsea Therapeutics International

(

CHTP

), down 8.1% , were all laggards within the health care sector with

Teva Pharmaceutical Industries

(

TEVA

) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null